Neuland Laboratories Hits New 52-Week High of Rs. 19,748.4
Neuland Laboratories has achieved a new 52-week high, reflecting strong performance in the pharmaceutical sector. The company has shown consistent upward momentum, with significant gains over recent days. It reported impressive financial metrics, including record operating cash flow and net sales, highlighting its growth potential and stability.
Neuland Laboratories has reached a significant milestone by hitting a new 52-week high of Rs. 19,748.4 on November 10, 2025. This achievement marks a notable performance for the small-cap pharmaceutical and biotechnology company, which has outperformed its sector by 1.64% today. The stock has shown consistent upward momentum, gaining 3.98% over the last two days and opening with a substantial gain of 6.11%. Intraday trading saw the stock peak at Rs. 19,748.4, reflecting a 10.81% increase. Neuland Laboratories is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong market position.
In the past year, Neuland Laboratories has delivered a robust return of 31.24%, significantly outperforming the Sensex, which has risen by only 5.21% during the same period. The company has also reported impressive financial metrics, including a record operating cash flow of Rs. 317.38 crore and net sales of Rs. 514.27 crore in the latest quarter. With high institutional holdings at 34.55%, Neuland Laboratories continues to demonstrate its capacity for growth and stability in the competitive pharmaceutical landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
